Highlights Medlive Technology Co., Ltd.

Equities

2192

KYG5961B1041

Market Closed - Hong Kong S.E. Other stock markets 04:08:17 2024-05-17 EDT			5-day change	1st Jan Change
8.88 ^HKD	+6.09%		+4.96%	+4.72%

04-29	Medlive Technology More than Doubles Profit in 2023	MT
03-25	Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Medlive Technology More than Doubles Profit in 2023	04-29	MT
Medlive Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on June 24, 2024	03-25	CI
Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-25	CI
Medlive Technology to Double Profit in 2023	02-28	MT
Medlive Technology Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2023	02-28	CI
Medlive to Buy 60% of Chinese Pharma Consulting Firm for Some 34 Million Yuan	23-10-13	MT
Medlive Technology’s Profit Soars 266% in H1	23-08-30	MT
Medlive Technology Co., Ltd. Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 04 December 2023	23-08-29	CI
Medlive Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Medlive Technology to More than Triple H1 Profit	23-08-03	MT
Medlive Technology Co., Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2023	23-08-03	CI
Medlive Technology Unit to Buy 50% Stake in Beijing SCMedcon	23-06-13	MT
Medlive Technology Co., Ltd. Proposes Final Cash Dividend for the Year Ended December 31, 2022, Payable on July 10, 2023	23-03-23	CI
Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Medlive Technology's Profit to Rise in 2022	23-03-02	MT
Medlive Technology Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022	23-03-02	CI
M3's Fiscal Nine-month Attributable Profit Drops 30% on Increased Operating Costs	23-02-06	MT
M3's Fiscal H1 Attributable Profit Plunges 41% on High-base Effect	22-11-03	MT
Medlive Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
M3's Fiscal Q1 Attributable Profit Tumbles 23% on High-base Effect; Shares Rise 13%	22-07-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Medlive Technology Co., Ltd.

Equities

2192

KYG5961B1041

Highlights

Filters